The IFM Therapeutics brand, founded in 2015 (United States), from 2951 sister brands and 17477 competing brands. IFM Therapeutics is owned by NOVARTIS N, listed on the stock exchange of Zurich The International Securities Identification Number (ISIN) of NOVARTIS N is CH0012005267. IFM Therapeutics is part of the Drug Manufacturers activity sector.
Investment simulator :
Portfolio valuation
NOVARTIS N
(IFM Therapeutics)
over 5 years*
CHF 101.45